Akbar Novan Dwi Saputra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akbar Novan Dwi Saputra has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Dicky Moch Rizal
Department of Physiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281
5 shared publications - Muhammad Nurhadi Rahman
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
4 shared publications - Anis Widyasari
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya
2 shared publications - Dwi Cahyani Ratna Sari
Department of Anatomy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281
2 shared publications Muhammad Nurhadi Rahman
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281
2 shared publicationsNandia Septiyorini
Department of Physiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281
2 shared publications
Latest Publications
- 28 January 2026
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (7) , 1915-1927
Patient-Related Risk Factors for Mesh Erosion Following Midurethral Sling Procedures: A Systematic Review and Meta-Analysis
Midurethral slings (MUS) are among the most commonly performed surgical treatments for stress urinary incontinence (SUI) worldwide, but mesh erosion remains a concerning complication. This systematic review and meta-analysis aimed to identify patient-related risk factors associated with mesh erosion following MUS procedures. We conducted a comprehensive literature search in MEDLINE via PubMed, ScienceDirect, and Scopus from January 2010 to March 2025. Studies reporting risk factors for mesh erosion following synthetic MUS procedures for SUI were included. Two independent reviewers assessed study quality using the Newcastle-Ottawa Scale. Evidence certainty was evaluated using the GRADE approach. Fixed-effects meta-analyses were performed to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Six high-quality studies (n = 3068 patients) were included. The prevalence of mesh erosion ranged from 1.3% to 13.7% across studies. Significant risk factors for mesh erosion included prior pelvic surgery (OR 10.37; 95% CI 6.70-16.07), diabetes mellitus (OR 4.63; 95% CI 3.44-6.25), smoking (OR 3.38; 95% CI 2.54-4.48), obesity (BMI ≥ 30 kg/m2) (OR 2.79; 95% CI 1.69-4.62), and postmenopausal status (OR 2.34; 95% CI 1.67-3.27). GRADE assessment indicated moderate-certainty evidence for prior pelvic surgery, diabetes mellitus, smoking, and postmenopausal status. This meta-analysis identifies prior pelvic surgery, postmenopausal status, diabetes mellitus, smoking, and obesity (BMI ≥ 30 kg/m2) as significant risk factors for mesh erosion following MUS procedures. These findings provide an evidence-based foundation for preoperative risk stratification and patient counseling. Prospero CRD420251026364.
- 28 January 2026
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (7) , 1915-1927
Patient-Related Risk Factors for Mesh Erosion Following Midurethral Sling Procedures: A Systematic Review and Meta-Analysis
Midurethral slings (MUS) are among the most commonly performed surgical treatments for stress urinary incontinence (SUI) worldwide, but mesh erosion remains a concerning complication. This systematic review and meta-analysis aimed to identify patient-related risk factors associated with mesh erosion following MUS procedures. We conducted a comprehensive literature search in MEDLINE via PubMed, ScienceDirect, and Scopus from January 2010 to March 2025. Studies reporting risk factors for mesh erosion following synthetic MUS procedures for SUI were included. Two independent reviewers assessed study quality using the Newcastle-Ottawa Scale. Evidence certainty was evaluated using the GRADE approach. Fixed-effects meta-analyses were performed to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Six high-quality studies (n = 3068 patients) were included. The prevalence of mesh erosion ranged from 1.3% to 13.7% across studies. Significant risk factors for mesh erosion included prior pelvic surgery (OR 10.37; 95% CI 6.70-16.07), diabetes mellitus (OR 4.63; 95% CI 3.44-6.25), smoking (OR 3.38; 95% CI 2.54-4.48), obesity (BMI ≥ 30 kg/m2) (OR 2.79; 95% CI 1.69-4.62), and postmenopausal status (OR 2.34; 95% CI 1.67-3.27). GRADE assessment indicated moderate-certainty evidence for prior pelvic surgery, diabetes mellitus, smoking, and postmenopausal status. This meta-analysis identifies prior pelvic surgery, postmenopausal status, diabetes mellitus, smoking, and obesity (BMI ≥ 30 kg/m2) as significant risk factors for mesh erosion following MUS procedures. These findings provide an evidence-based foundation for preoperative risk stratification and patient counseling. Prospero CRD420251026364.
- Open Access
- 16 September 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1056
Effect of human platelet-rich fibrin lysate on collagen type I, collagen type III, and matrix metalloproteinase 1: a protocol study on rat models with pelvic organ prolapse
Background Pelvic organ prolapse (POP) is a prevalent condition caused by weakened pelvic floor support structures. Extracellular matrix alterations, including changes in collagen type I, collagen type III, and matrix metalloproteinase 1 (MMP-1), contribute to the pathogenesis of this condition. Human platelet-rich fibrin lysate (hPRF-L) is a novel regenerative treatment that has shown beneficial results in treating structural weaknesses related to various pelvic floor diseases, including POP. Methods This study protocol aims to investigate the effects of hPRF-L injection on collagen I, III, and MMP-1 in the vaginal mucosa of a rat POP model. POP will be induced in female Sprague-Dawley rats, which will be randomly assigned to control, sham, and hPRF-L treatment groups. The hPRF-L group will receive weekly injections of hPRF-L (25, 50, or 75 μL) into the vaginal mucosa for 4 weeks. Vaginal tissue samples will be collected, and collagen type I, collagen type III, and MMP-1 expression will be evaluated using quantitative reverse transcription polymerase chain reaction and immunohistochemical analyses. Data analysis will be performed with ANOVA and post-hoc tests. Discussion The findings from this study protocol are expected to provide valuable insights into the mechanisms by which hPRF-L impacts the structural integrity of the pelvic floor. By elucidating these mechanisms, this study aims to inform future POP treatment strategies. The anticipated results are an increase in collagen type I and III expression and a reduction in MMP-1 levels in the hPRF-L treatment group compared to the control and sham groups. These outcomes could support the use of hPRF-L as a regenerative therapy for managing POP, offering a potential alternative to more invasive surgical interventions. Conclusion The expected results will contribute to the development of less invasive treatments for POP, improving patient outcomes and quality of life.
- 16 September 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1056
Open AccessEffect of human platelet-rich fibrin lysate on collagen type I, collagen type III, and matrix metalloproteinase 1: a protocol study on rat models with pelvic organ prolapse
Background Pelvic organ prolapse (POP) is a prevalent condition caused by weakened pelvic floor support structures. Extracellular matrix alterations, including changes in collagen type I, collagen type III, and matrix metalloproteinase 1 (MMP-1), contribute to the pathogenesis of this condition. Human platelet-rich fibrin lysate (hPRF-L) is a novel regenerative treatment that has shown beneficial results in treating structural weaknesses related to various pelvic floor diseases, including POP. Methods This study protocol aims to investigate the effects of hPRF-L injection on collagen I, III, and MMP-1 in the vaginal mucosa of a rat POP model. POP will be induced in female Sprague-Dawley rats, which will be randomly assigned to control, sham, and hPRF-L treatment groups. The hPRF-L group will receive weekly injections of hPRF-L (25, 50, or 75 μL) into the vaginal mucosa for 4 weeks. Vaginal tissue samples will be collected, and collagen type I, collagen type III, and MMP-1 expression will be evaluated using quantitative reverse transcription polymerase chain reaction and immunohistochemical analyses. Data analysis will be performed with ANOVA and post-hoc tests. Discussion The findings from this study protocol are expected to provide valuable insights into the mechanisms by which hPRF-L impacts the structural integrity of the pelvic floor. By elucidating these mechanisms, this study aims to inform future POP treatment strategies. The anticipated results are an increase in collagen type I and III expression and a reduction in MMP-1 levels in the hPRF-L treatment group compared to the control and sham groups. These outcomes could support the use of hPRF-L as a regenerative therapy for managing POP, offering a potential alternative to more invasive surgical interventions. Conclusion The expected results will contribute to the development of less invasive treatments for POP, improving patient outcomes and quality of life.
- 6 February 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 36 (4) , 941-942
Response to Letter to the Editor: “Type III Collagen RNA Level Expression in Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis”
- 6 February 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 36 (4) , 941-942
Response to Letter to the Editor: “Type III Collagen RNA Level Expression in Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis”
- 1 October 2024
- Published by Springer Nature in International Urogynecology Journal
- Vol. 35 (11) , 2097-2106
Type III Collagen RNA Level Expression in Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis
Introduction and Hypothesis Changes in the expression of type III collagen have been linked to women's predisposition to pelvic organ prolapse (POP); however, the findings of prior studies have been conflicting. This study was aimed at investigating whether changes in the type III collagen gene expression levels occur in POP development. Methods A systematic review and meta-analysis were conducted on research articles that evaluated type III collagen gene expression levels in patients with POP compared with those without the condition. The articles, published between January 2000 and February 2024, were obtained from PubMed, ScienceDirect, Semantic Scholar, and EBSCO databases. Data were analyzed using fixed-effect models, and the pooled standardized mean difference (SMD) was calculated. Cochrane’s Review Manager 5.4 was used for the analysis. The aggregated SMD with 95% confidence interval (CI) regarding type III collagen gene expression levels relative to POP development was the main outcome measure. Results with p < 0.05 were considered statistically significant. Results Six studies were included in our analysis, comprising 229 POP cases and 139 non-POP cases. Our meta-analysis indicated that patients with POP had higher type III collagen gene expression levels than those without POP (SMD = 0.32; 95% CI: 0.07 to 0.56; p = 0.01). Conclusion The results of this study provide evidence that a higher type III collagen gene expression levels is significantly associated with POP.
- 1 October 2024
- Published by Springer Nature in International Urogynecology Journal
- Vol. 35 (11) , 2097-2106
Type III Collagen RNA Level Expression in Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis
Introduction and Hypothesis Changes in the expression of type III collagen have been linked to women's predisposition to pelvic organ prolapse (POP); however, the findings of prior studies have been conflicting. This study was aimed at investigating whether changes in the type III collagen gene expression levels occur in POP development. Methods A systematic review and meta-analysis were conducted on research articles that evaluated type III collagen gene expression levels in patients with POP compared with those without the condition. The articles, published between January 2000 and February 2024, were obtained from PubMed, ScienceDirect, Semantic Scholar, and EBSCO databases. Data were analyzed using fixed-effect models, and the pooled standardized mean difference (SMD) was calculated. Cochrane’s Review Manager 5.4 was used for the analysis. The aggregated SMD with 95% confidence interval (CI) regarding type III collagen gene expression levels relative to POP development was the main outcome measure. Results with p < 0.05 were considered statistically significant. Results Six studies were included in our analysis, comprising 229 POP cases and 139 non-POP cases. Our meta-analysis indicated that patients with POP had higher type III collagen gene expression levels than those without POP (SMD = 0.32; 95% CI: 0.07 to 0.56; p = 0.01). Conclusion The results of this study provide evidence that a higher type III collagen gene expression levels is significantly associated with POP.
- Open Access
- 13 September 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1056
Effect of Human Platelet-Rich Fibrin Lysate on Collagen Type I, Collagen Type III, and Matrix Metalloproteinase 1: A Protocol Study on Rat Models with Pelvic Organ Prolapse
Background Pelvic organ prolapse (POP) is a prevalent condition caused by weakened pelvic floor support structures. Extracellular matrix alterations, including changes in collagen type I, collagen type III, and matrix metalloproteinase 1 (MMP-1), contribute to the pathogenesis of this condition. Human platelet-rich fibrin lysate (hPRF-L) is a novel regenerative treatment that has shown beneficial results in treating structural weaknesses related to various pelvic floor diseases, including POP. Methods This study protocol aims to investigate the effects of hPRF-L injection on collagen I, III, and MMP-1 in the vaginal mucosa of a rat POP model. POP will be induced in female Sprague-Dawley rats, which will be randomly assigned to control, sham, and hPRF-L treatment groups. The hPRF-L group will receive weekly injections of hPRF-L (25, 50, or 75 μL) into the vaginal mucosa for 4 weeks. Vaginal tissue samples will be collected, and collagen type I, collagen type III, and MMP-1 expression will be evaluated using quantitative reverse transcription polymerase chain reaction and immunohistochemical analyses. Data analysis will be performed with ANOVA and post-hoc tests. Discussion The findings from this study protocol are expected to provide valuable insights into the mechanisms by which hPRF-L impacts the structural integrity of the pelvic floor. By elucidating these mechanisms, this study aims to inform future POP treatment strategies. The anticipated results are an increase in collagen type I and III expression and a reduction in MMP-1 levels in the hPRF-L treatment group compared to the control and sham groups. These outcomes could support the use of hPRF-L as a regenerative therapy for managing POP, offering a potential alternative to more invasive surgical interventions. Conclusion The expected results will contribute to the development of less invasive treatments for POP, improving patient outcomes and quality of life.
- 13 September 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1056
Open AccessEffect of Human Platelet-Rich Fibrin Lysate on Collagen Type I, Collagen Type III, and Matrix Metalloproteinase 1: A Protocol Study on Rat Models with Pelvic Organ Prolapse
Background Pelvic organ prolapse (POP) is a prevalent condition caused by weakened pelvic floor support structures. Extracellular matrix alterations, including changes in collagen type I, collagen type III, and matrix metalloproteinase 1 (MMP-1), contribute to the pathogenesis of this condition. Human platelet-rich fibrin lysate (hPRF-L) is a novel regenerative treatment that has shown beneficial results in treating structural weaknesses related to various pelvic floor diseases, including POP. Methods This study protocol aims to investigate the effects of hPRF-L injection on collagen I, III, and MMP-1 in the vaginal mucosa of a rat POP model. POP will be induced in female Sprague-Dawley rats, which will be randomly assigned to control, sham, and hPRF-L treatment groups. The hPRF-L group will receive weekly injections of hPRF-L (25, 50, or 75 μL) into the vaginal mucosa for 4 weeks. Vaginal tissue samples will be collected, and collagen type I, collagen type III, and MMP-1 expression will be evaluated using quantitative reverse transcription polymerase chain reaction and immunohistochemical analyses. Data analysis will be performed with ANOVA and post-hoc tests. Discussion The findings from this study protocol are expected to provide valuable insights into the mechanisms by which hPRF-L impacts the structural integrity of the pelvic floor. By elucidating these mechanisms, this study aims to inform future POP treatment strategies. The anticipated results are an increase in collagen type I and III expression and a reduction in MMP-1 levels in the hPRF-L treatment group compared to the control and sham groups. These outcomes could support the use of hPRF-L as a regenerative therapy for managing POP, offering a potential alternative to more invasive surgical interventions. Conclusion The expected results will contribute to the development of less invasive treatments for POP, improving patient outcomes and quality of life.
- Open Access
- 13 May 2024
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2024, 1-5
Removal of Complete Spontaneous Migration of an Intrauterine Contraceptive Device to the Bladder by Cystoscopy
Intrauterine contraceptive devices (IUCD) are widely used as a reversible method of contraception. Although uterine perforation caused by an IUCD is rare, in some cases, the device may migrate to the pelvic/abdominal cavity or nearby structures. When the IUCD migrate to the bladder, it can lead to various symptoms. These include pain or discomfort in the lower abdomen, difficulties or pain during urination, frequent urinary tract infections, and the development of bladder stones. This article presents a case report of a 24-year-old woman with an intrauterine contraceptive device (IUCD) that had migrated completely into the bladder. She had an IUCD inserted by a midwife four years earlier and became pregnant a year later, unaware of the IUCD’s presence. She later presented with lower abdominal pain, hematuria, and dysuria three months before being admitted to our hospital. Imaging confirmed the intravesical location of the IUCD. She underwent successful cystoscopy treatment to remove the migrated IUCD. Prompt diagnosis and appropriate management are crucial in preventing complications and improving patient outcomes. Clinicians should be aware of this potential complication and consider it when patients present with symptoms or complications after IUCD insertion. Regular monitoring and timely intervention can help detect and address IUCD migration effectively.
- 13 May 2024
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2024, 1-5
Open AccessRemoval of Complete Spontaneous Migration of an Intrauterine Contraceptive Device to the Bladder by Cystoscopy
Intrauterine contraceptive devices (IUCD) are widely used as a reversible method of contraception. Although uterine perforation caused by an IUCD is rare, in some cases, the device may migrate to the pelvic/abdominal cavity or nearby structures. When the IUCD migrate to the bladder, it can lead to various symptoms. These include pain or discomfort in the lower abdomen, difficulties or pain during urination, frequent urinary tract infections, and the development of bladder stones. This article presents a case report of a 24-year-old woman with an intrauterine contraceptive device (IUCD) that had migrated completely into the bladder. She had an IUCD inserted by a midwife four years earlier and became pregnant a year later, unaware of the IUCD’s presence. She later presented with lower abdominal pain, hematuria, and dysuria three months before being admitted to our hospital. Imaging confirmed the intravesical location of the IUCD. She underwent successful cystoscopy treatment to remove the migrated IUCD. Prompt diagnosis and appropriate management are crucial in preventing complications and improving patient outcomes. Clinicians should be aware of this potential complication and consider it when patients present with symptoms or complications after IUCD insertion. Regular monitoring and timely intervention can help detect and address IUCD migration effectively.
- Open Access
- 16 January 2023
- Published by MedCrave Group Kft. in International Journal of Family & Community Medicine
- Vol. 7 (1) , 7-9
Community empowerment and elderly integrated service post to improve the health of elderly women in Ngaglik Sleman
Currently, Indonesia is experiencing a dramatic demographic shift caused by the explosion of the elderly population, or people aged 60 years and older. In 2017, Special Region of Yogyakarta was the province with the highest elderly population in Indonesia. The increase of the elderly population requires action from all parties in anticipating various problems related to the elderly, especially elderly women, including their reproductive health, mental health, and change of nutrition needed. The peri and postmenopausal period constitutes a challenging transition time for women’s health, and menopausal health is a crucial aspect in healthy and successful aging. Sleman Regency Government has implemented community-based health service or elderly integrated service post. Health care volunteers (cadres) play an essential role in carrying out the objectives of an elderly integrated service post. Therefore, it requires knowledge and skills enhancement of the cadres about elderly women’s health. Training that included lectures and discussion could improve the knowledge and skills of women elderly health cadres, provide the optimal quality of health service in elderly integrated service post, and increase public awareness about the importance of health services in providing health information for the women elderly.
- 16 January 2023
- Published by MedCrave Group Kft. in International Journal of Family & Community Medicine
- Vol. 7 (1) , 7-9
Open AccessCommunity empowerment and elderly integrated service post to improve the health of elderly women in Ngaglik Sleman
Currently, Indonesia is experiencing a dramatic demographic shift caused by the explosion of the elderly population, or people aged 60 years and older. In 2017, Special Region of Yogyakarta was the province with the highest elderly population in Indonesia. The increase of the elderly population requires action from all parties in anticipating various problems related to the elderly, especially elderly women, including their reproductive health, mental health, and change of nutrition needed. The peri and postmenopausal period constitutes a challenging transition time for women’s health, and menopausal health is a crucial aspect in healthy and successful aging. Sleman Regency Government has implemented community-based health service or elderly integrated service post. Health care volunteers (cadres) play an essential role in carrying out the objectives of an elderly integrated service post. Therefore, it requires knowledge and skills enhancement of the cadres about elderly women’s health. Training that included lectures and discussion could improve the knowledge and skills of women elderly health cadres, provide the optimal quality of health service in elderly integrated service post, and increase public awareness about the importance of health services in providing health information for the women elderly.
- 21 May 2022
- Published by Springer Nature in International Urogynecology Journal
- Vol. 33 (7) , 1803-1812
The difference in collagen type-1 expression in women with and without pelvic organ prolapse: a systematic review and meta-analysis
Introduction and hypothesis This study was aimed at identifying the difference in collagen type-1 expression in women with and without pelvic organ prolapse (POP). Methods A systematic review and meta-analysis was carried out women with and without pelvic organ prolapse. This meta-analysis was conducted on research articles describing the evaluation of collagen type-1 expression between patients with and without POP. The articles were obtained from PubMed, EBSCO, and ProQuest, and were published between January 2000 and June 2021. Pooled mean difference (MD) and pooled odds ratio (OR) were calculated using fixed effect models. Review Manager (RevMan 5.4) was used to analyze the data. The main outcome measures were pooled MD and pooled OR of collagen type-1 expression in patients with and without POP. Results A total of seven case–control studies were included in the meta-analysis using the effect size of the MD and two case–control studies were included in the meta-analysis using the effect size of the OR. A total of 247 POP cases and 132 non-POP cases were identified from the studies. Our study indicated that patients with POP had a lower level of collagen type-1 expression than non-POP patients (MD = −6.77; 95% CI: −8.37, −5.17, p < 0.00001). Patients with low expression of collagen type-1 in pelvic support tissue are at a more than 3 times higher risk of suffering from pelvic organ prolapse (OR = 3.23, 95% CI: 1.52 to 6.87, p = 0.002). Conclusion The results of this study showed that patients with pelvic organ prolapse have lower expression of collagen type-1 than nonpelvic organ prolapse patients.
- 21 May 2022
- Published by Springer Nature in International Urogynecology Journal
- Vol. 33 (7) , 1803-1812
The difference in collagen type-1 expression in women with and without pelvic organ prolapse: a systematic review and meta-analysis
Introduction and hypothesis This study was aimed at identifying the difference in collagen type-1 expression in women with and without pelvic organ prolapse (POP). Methods A systematic review and meta-analysis was carried out women with and without pelvic organ prolapse. This meta-analysis was conducted on research articles describing the evaluation of collagen type-1 expression between patients with and without POP. The articles were obtained from PubMed, EBSCO, and ProQuest, and were published between January 2000 and June 2021. Pooled mean difference (MD) and pooled odds ratio (OR) were calculated using fixed effect models. Review Manager (RevMan 5.4) was used to analyze the data. The main outcome measures were pooled MD and pooled OR of collagen type-1 expression in patients with and without POP. Results A total of seven case–control studies were included in the meta-analysis using the effect size of the MD and two case–control studies were included in the meta-analysis using the effect size of the OR. A total of 247 POP cases and 132 non-POP cases were identified from the studies. Our study indicated that patients with POP had a lower level of collagen type-1 expression than non-POP patients (MD = −6.77; 95% CI: −8.37, −5.17, p < 0.00001). Patients with low expression of collagen type-1 in pelvic support tissue are at a more than 3 times higher risk of suffering from pelvic organ prolapse (OR = 3.23, 95% CI: 1.52 to 6.87, p = 0.002). Conclusion The results of this study showed that patients with pelvic organ prolapse have lower expression of collagen type-1 than nonpelvic organ prolapse patients.
- Open Access
- 11 May 2022
- Published by Springer Nature in Research Square
The efficacy of platelet rich plasma in pelvic organ prolapse surgery : A protocol for scoping review
Background : Platelet-rich plasma (PRP) is an autologous, self-blood product, anticoagulated blood product generated by centrifugation method of whole blood that primarily contains platelets at amounts up to 5 times those found in physiologic platelet concentrations. PRP contains multiple growth factors such as transforming growth factor (TGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and insulin-like growth factor-1 within the alpha granules of platelets (IGF-1). Platelets also contain antibacterial and fungicidal proteins, metalloproteinases, coagulation factors, and membrane glycoproteins, which can regulate inflammation by promoting the production of various integrins, interleukins, and chemokines. Pelvic organ prolapse occurs when the genitalia organ, bladder, rectum, and intestine protrude into the vaginal canal or even out of it due to the weakening of ligaments and muscles that serve as suspensors for the pelvic organs. Surgery is one of the treatment options for pelvic organ prolapse. The use of platelet rich plasma in pelvic organ prolapse surgery is becoming much more common. The goal of this procedure is to reconstruct the anatomical components of the pelvic supporting tissues and increase the healing process. To determine the efficacy of PRP on pelvic organ prolapse surgery, we will synthesize the available research on the use of platelet rich plasma for pelvic organ prolapse surgery. The goal of this study is to conduct a scoping study of the published research on the efficacy of platelet rich plasma for the surgery procedure of female pelvic organ prolapse. Methods/design : This review was conducted on research articles in PubMed, Proquest, EBSCO, ScienceDirect databases published between January 2010 – Desember 2021 regarding the use of platelet rich plasma for pelvic organ prolapse surgery. All primary research in human, case reports and case series will be included to evaluate the outcome of platelet rich plasma as an adjunct to conventional surgery in the treatment of pelvic organ prolapse. Discussion : This review will offer actual evidence of PRP's efficacy for pelvic organ prolapse surgery. This is a new approach, and the findings of this study are expected to inform clinical practice and ongoing research focused on improving outcome of pelvic organ prolapse surgery. Trial registration number : osf.io/gyr72
- 11 May 2022
- Published by Springer Nature in Research Square
Open AccessThe efficacy of platelet rich plasma in pelvic organ prolapse surgery : A protocol for scoping review
Background : Platelet-rich plasma (PRP) is an autologous, self-blood product, anticoagulated blood product generated by centrifugation method of whole blood that primarily contains platelets at amounts up to 5 times those found in physiologic platelet concentrations. PRP contains multiple growth factors such as transforming growth factor (TGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and insulin-like growth factor-1 within the alpha granules of platelets (IGF-1). Platelets also contain antibacterial and fungicidal proteins, metalloproteinases, coagulation factors, and membrane glycoproteins, which can regulate inflammation by promoting the production of various integrins, interleukins, and chemokines. Pelvic organ prolapse occurs when the genitalia organ, bladder, rectum, and intestine protrude into the vaginal canal or even out of it due to the weakening of ligaments and muscles that serve as suspensors for the pelvic organs. Surgery is one of the treatment options for pelvic organ prolapse. The use of platelet rich plasma in pelvic organ prolapse surgery is becoming much more common. The goal of this procedure is to reconstruct the anatomical components of the pelvic supporting tissues and increase the healing process. To determine the efficacy of PRP on pelvic organ prolapse surgery, we will synthesize the available research on the use of platelet rich plasma for pelvic organ prolapse surgery. The goal of this study is to conduct a scoping study of the published research on the efficacy of platelet rich plasma for the surgery procedure of female pelvic organ prolapse. Methods/design : This review was conducted on research articles in PubMed, Proquest, EBSCO, ScienceDirect databases published between January 2010 – Desember 2021 regarding the use of platelet rich plasma for pelvic organ prolapse surgery. All primary research in human, case reports and case series will be included to evaluate the outcome of platelet rich plasma as an adjunct to conventional surgery in the treatment of pelvic organ prolapse. Discussion : This review will offer actual evidence of PRP's efficacy for pelvic organ prolapse surgery. This is a new approach, and the findings of this study are expected to inform clinical practice and ongoing research focused on improving outcome of pelvic organ prolapse surgery. Trial registration number : osf.io/gyr72